BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36071287)

  • 1. Exploring the inverse association of glioblastoma multiforme and Alzheimer's disease via bioinformatics analysis.
    Cai J; Ye L; Hu Y; Ye Z; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Med Oncol; 2022 Sep; 39(12):182. PubMed ID: 36071287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
    Güven E; Afzal M; Kazmi I
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
    Akçay S; Güven E; Afzal M; Kazmi I
    Gene; 2022 May; 824():146395. PubMed ID: 35283227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
    Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
    Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
    Kabir F; Apu MNH
    Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Associations between Alzheimer's Disease and GBM Mediated by Microglia Based on Network Analysis.
    Zhang C; Zhong X; Yi L; Zhao Z; Zhang Y; Tan G; Zhang Y; Zhang Y; Xu Y; Wu N
    J Prev Alzheimers Dis; 2023; 10(2):267-275. PubMed ID: 36946454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA.
    Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
    Biomed Res Int; 2018; 2018():4246703. PubMed ID: 30356407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC12A5 as a novel potential biomarker of glioblastoma multiforme.
    Chen J; Wang H; Deng C; Fei M
    Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
    Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
    BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm.
    Ji W; An K; Wang C; Wang S
    Hereditas; 2022 Oct; 159(1):38. PubMed ID: 36195955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Systems Level Molecular Signatures from Glioblastoma Multiforme Derived Extracellular Vesicles.
    Roy N; Gaikwad M; Bhattacharrya DK; Barah P
    J Mol Neurosci; 2021 Jun; 71(6):1156-1167. PubMed ID: 33231813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of upregulated genes in glioblastoma and glioblastoma cancer stem cells using bioinformatics analysis.
    Caglar HO; Duzgun Z
    Gene; 2023 Jan; 848():146895. PubMed ID: 36122609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.